Agios Pharmaceuticals (AGIO) Other Operating Expenses (2017 - 2026)
Agios Pharmaceuticals' (AGIO) quarterly Other Operating Expenses came in at $3.0 million in Q2 2026, up 76.03% YoY from $1.7 million in Q2 2025, and up 127.14% on a QoQ basis from $1.3 million in Q1 2026.
Agios Pharmaceuticals (AGIO) Other Operating Expenses (2017 - 2026) Analysis & Trends
Agios Pharmaceuticals (AGIO) has 9 years of Other Operating Expenses data on file, last reported at $3.0 million in Q2 2026.
- Quarterly Other Operating Expenses rose 76.03% year-over-year to $3.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $4.3 million (down 97.87% YoY) and the FY2024 annual result came in at $200.0 million, changed N/A from the prior year.
- Other Operating Expenses grew to $3.0 million in Q2 2026, from $1.3 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $200.0 million in Q3 2024 to a low of -$9.9 million in Q4 2022.
- A 5-year average of $16.2 million and a median of $1.5 million in 2024 frame the typical range for Other Operating Expenses.
- The widest YoY moves for Other Operating Expenses: up 122.15% in 2022, down 475.14% in 2022.
- Tracing AGIO's Other Operating Expenses over 5 years: stood at -$9.9 million in 2022, then jumped by 111.19% to $1.1 million in 2023, then surged by 17950.54% to $200.0 million in 2024, then sank by 99.15% to $1.7 million in 2025, then jumped by 76.03% to $3.0 million in 2026.
- The last three Other Operating Expenses figures came in at $3.0 million (Q2 2026), $1.3 million (Q1 2026), and $1.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Agios Pharmaceuticals | 2.00 Bn | 1.38 Bn | 41.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.00 Mn |
| Mar 31, 2026 | 1.32 Mn |
| Jun 30, 2025 | 1.70 Mn |
| Mar 31, 2025 | 1.09 Mn |
| Sep 30, 2024 | 200.00 Mn |
| Jun 30, 2024 | 1.50 Mn |
| Mar 31, 2024 | 627,000.00 |
| Jun 30, 2023 | 1.11 Mn |
| Mar 31, 2023 | 554,000.00 |
| Dec 31, 2022 | -9.85 Mn |
| Sep 30, 2022 | 4.44 Mn |
| Jun 30, 2022 | 2.70 Mn |
| Mar 31, 2022 | 2.97 Mn |
| Dec 31, 2021 | 2.64 Mn |
| Sep 30, 2021 | 2.00 Mn |
| Jun 30, 2021 | 2.00 Mn |
| Dec 31, 2019 | -1.03 Mn |
| Sep 30, 2019 | 393,000.00 |
| Jun 30, 2019 | 303,000.00 |
| Mar 31, 2019 | 334,000.00 |